Ascletis Pharmaceuticals
As of the edition of 20 October 2026, Ascletis Pharmaceuticals runs 13 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
The records place 2 company names in this family.
Drugs by status
| Status | Count |
|---|---|
| Active | 3 |
| Went quiet | 3 |
| Stopped | 4 |
| Status not established | 3 |
| Total | 13 |
Where its trials are
- Infections: 10 trials led
- Digestive system: 6 trials led
- Lungs and airways: 3 trials led